junctional epidermolysis bullosa, non-Herlitz type

The information provided on this page is for informational purposes only. The National Organization for Rare Disorders (NORD) does not endorse the information presented. The content has been gathered in partnership with the MONDO Disease Ontology. Please consult with a healthcare professional for medical advice and treatment.

Print

Disease Overview

Junctional epidermolysis bullosa, non-Herlitz (JEB-nH) is a subtype of junctional epidermolysis bullosa (JEB) characterized by the presence of skin and mucosal blistering, nail dystrophy or nail absence and enamel hypoplasia.


Synonyms

  • JEB-I
  • JEB-nH
  • JEN-nH
  • epidermolysis bullosa Junctionalis, Disentis type
  • epidermolysis bullosa Junctionalis, non-Herlitz type
  • epidermolysis bullosa Junctionalis, progressive
  • epidermolysis bullosa Junctionalis, severe Nonlethal
  • epidermolysis bullosa, generalised atrophic benign
  • epidermolysis bullosa, generalized atrophic benign
  • epidermolysis bullosa, junctional, Localisata variant
  • epidermolysis bullosa, junctional, non-Herlitz type
  • junctional epidermolysis bullosa inversa

Orphanet

Orphanet has a summary about this condition that may include information on the diagnosis, care, and treatment as well as other resources. Some of the information and resources are available in languages other than English. The summary may include medical terms, so we encourage you to share and discuss this information with your doctor. Orphanet is the French National Institute for Health and Medical Research and the Health Programme of the European Union.

View report
OMIM

Online Mendelian Inheritance In Man (OMIM) has a summary of published research about this condition and includes references from the medical literature. The summary contains medical and scientific terms, so we encourage you to share and discuss this information with your doctor. OMIM is authored and edited at the McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine.

View report